ABSTRACT To elucidate the mechanisms by which the new bipyridine inotropic agent milrinone improves cardiac function, we examined multiple indexes of left ventricular diastolic function before and after administration of milrinone to patients with advanced (NYHA class III or IV) congestive heart failure. In 13 patients left ventricular pressure measurements were made with a micromanometer to permit assessment of peak negative dP/dt and the time constant of left ventricular isovolumic relaxation, T, before and after milrinone. In nine patients radionuclide ventriculographic studies were performed during left heart catheterization, allowing calculation of left ventricular peak filling rate, volumes, and the diastolic pressure-volume relationship before and after milrinone. After intravenous administration of milrinone, peak negative dP/dt increased ( + 18%; p < .01 ) and T decreased (-30%; p < .01), while heart rate increased by only 8% (87 + 12 to 94 + 15 beats/min; p < .01), left ventricular systolic pressure did not change, and mean aortic pressure fell by 11% (p < .01). Left ventricular peak filling rate increased (1.2 + 0.6 to 1.7 + 0.7 end-diastolic volumes/sec; p .02) despite a decrease in left ventricular filling pressure (mean pulmonary wedge pressure 27 ± 7 to 18 9 mm Hg; p < .01). There was a fall in left ventricular end-diastolic pressure (28.6 + 6 to 19 + 7 mm Hg; p ' .01), with no significant change in left ventricular end-diastolic volume. This was associated with a downward shift in the left ventricular diastolic pressure-volume relationship in most cases. These changes in parameters of left ventricular diastolic relaxation and chamber distensibility after administration of milrinone suggest that improved diastolic function may contribute to the beneficial hemodynamic effect of milrinone in patients with congestive heart failure. Circulation 70, No. 6, 1030-1037 , 1984 MILRINONE, a derivative of the bipyridine inotrope amrinone, has previously been shown to have a profound effect on myocardial contractile function in isolated muscle' and animal preparations.2 The clinical response of patients with congestive heart failure who are treated with this agent has been ascribed to readily demonstrable improvements in indexes of left ventricFrom the Charles A.
MILRINONE, a derivative of the bipyridine inotrope amrinone, has previously been shown to have a profound effect on myocardial contractile function in isolated muscle' and animal preparations. 2 The clinical response of patients with congestive heart failure who are treated with this agent has been ascribed to readily demonstrable improvements in indexes of left ventric-ular systolic function (including increases in peak positive dP/dt and in left ventricular ejection fraction) and concurrent arteriolar vasodilation. 3 However, possible effects of milrinone on ventricular diastolic function, which might also contribute to the hemodynamic response to this agent, have not been evaluated. In particular, improved diastolic relaxation and distensibility might lead to more effective sarcomere stretch within the ventricular myocardium and to better systolic performance.6 7 Thus it is possible that improved systolic pump function in patients with heart failure treated with milrinone might reflect a complex interaction of effects of the drug on systolic and diastolic properties of the ventricular myocardium as well as changes in the peripheral vasculature. In this study we examined the effects of milrinone on multiple indexes of left ventricular diastolic function in patients with advanced congestive heart failure.
THERAPY AND PREVENTION-cONGESTIVE HEART FAILURE Methods Seventeen patients with advanced congestive heart failure (NYHA class III or IV) refractory to standard medical therapy were studied. The group included patients with ischemic cardiomyopathy (cardiomyopathy associated with extensive prior infarction, n = 10), idiopathic dilated cardiomyopathy (n = 5), dilated cardiomyopathy in association with surgically corrected valvular heart disease (n = 1), and postmyocarditis cardiomyopathy (n = 1) (see table 1 Each of the 17 patients underwent right and left heart catheterization. Right heart studies were done with No. 7F thermodilution Swan-Ganz catheters (Edwards Laboratories, Santa Ana, CA). Left heart studies were done with micromanometer catheters (Millar Instruments, Houston) in 13 figure 2 . There was an increase in the peak left ventricular filling rate for the group as a whole after administration of milrinone (1.2 ± 0.6 to 1.7 + 0.7 EDV/sec; p ' .02), as seen in figure 3 . This occurred despite a significant fall in the mean pulmonary capillary wedge pressure (the driving force for left ventricular filling) in these patients ( figure 3) . Furthermore, this increase in left ventricular peak filling rate was observed in all but one 1 It is probable that left ventricular systolic and diastolic function and dysfunction are "coupled" physiologic processes"2 and that the biochemical processes underlying some types of heart failure might affect myocardial relaxation as well as contraction. 23 Furthermore, it is also likely that failure of complete left ventricular myocardial relaxation could contribute to the abnormality seen in left ventricular systolic func-PRE POST MILRINONE A previous study reported altered early relaxation in patients with congestive (dilated) cardiomyopathy and heart failure, as supported by markedly depressed values for both peak negative dP/dt and velocity of circumferential fiber lengthening in early diastole. '5 In this study three indexes of early diastolic relaxation maximum negative dP/dt, the time constant (T) of left ventricular isovolumic relaxation, and left ventricular peak filling rate each showed a significant abnormality in control measurements that improved after administration of milrinone. This was seen despite the absence of a parallel directional change in, or even in 1034 the presence of an opposite directional influence of, a major hemodynamic detereminant of each of these indexes. Specifically, peak negative dP/dt showed an increase of 18% in the absence of a significant change in peak left ventricular pressure and in association with a fall in mean arterial pressure. A decrease in arterial pressure should have caused a fall in peak negative dP/ dtt; since we observed a rise in peak negative dP/dt after milrinone, it seems reasonable to conclude that relaxation was improved by the milrinone rather than by some peripheral effect of milrinone on left ventricular loading. This improved relaxation is also suggested by the shortening of the relaxation time (as reflected by the time constant T) after milrinone whether T was calculated by the logarithmic method8 or the derivative method.9 Finally, improved relaxation after milrinone is supported by the measurements of peak filling rate. 24 In the nine patients evaluated with simultaneous radionuclide ventriculography and hemodynamic studies, left ventricular peak filling rate showed a 42% increase despite a 33% fall in the left atrial (pulmonary capillary wedge) pressure. A primary fall in filling pressure should have caused a decrease in peak filling rate25 rather than the increase we noted.
Middle and late diastolic left ventricular filling, as reflected in the left ventricular pressure-volume relationship, showed a similar improvement. There was a 31% fall in left ventricular end-diastolic pressure with- in peak negative dP/dt but also to a fall in T. Calcium infusion33 led to no significant change in peak negative dP/dt but to a fall in T. Digoxin administration36 led to no significant change in peak negative dP/dt. Thus an increase in contractility by itself does not necessarily lead to more rapid myocardial relaxation, and the mechanics of contraction and relaxation are frequently dissociated.37 Finally, the potential effects of coronary artery disease and myocardial ischemia on left ventricular relaxation need to be considered.38-4 Since 10 of our 17 patients had coronary artery disease, baseline prolongation of T may have somehow reflected resting ischemia or dyssynchrony of left ventricular contraction. However, similar findings in T were noted in the patients without coronary disease.
The pressure asymptote, PB calculated in the patients in whom TD and TL were determined, showed wide scatter and no significant change after milrinone. Our control value for PB (-6 + 15 mm Hg) was similar to that reported by Carroll et al .38 in their "scar group" (five patients with coronary disease and prior infarction) where P was -7 ± 10 mm Hg. In their study, PB showed a significant change only in patients who developed myocardial ischemia with exercise. Thompson et al. 42 showed a similar wide range of variation in resting values for PB and point out that the relevance of PB to diastolic relaxation after mitral valve opening is uncertain. Since the physiologic meaning of PB is unclear, we cannot interpret its failure to change consistently with milrinone in this study.
Recently43 the effects of milrinone on excitation- 
